Fibroblast-mediated pathways in cardiac hypertrophy

K Fujiu, R Nagai - Journal of molecular and cellular cardiology, 2014 - Elsevier
K Fujiu, R Nagai
Journal of molecular and cellular cardiology, 2014Elsevier
Under normal physiological conditions, cardiac fibroblasts are the primary producers of
extracellular matrix and supply a mechanical scaffold for efficacious heart contractions
induced by cardiomyocytes. In the hypertrophic heart, cardiac fibroblasts provide a pivotal
contribution to cardiac remodeling. Many growth factors and extracellular matrix components
secreted by cardiac fibroblasts induce and modify cardiomyocyte hypertrophy. Recent
evidence revealed that cardiomyocyte–cardiac fibroblast communications are complex and …
Abstract
Under normal physiological conditions, cardiac fibroblasts are the primary producers of extracellular matrix and supply a mechanical scaffold for efficacious heart contractions induced by cardiomyocytes. In the hypertrophic heart, cardiac fibroblasts provide a pivotal contribution to cardiac remodeling. Many growth factors and extracellular matrix components secreted by cardiac fibroblasts induce and modify cardiomyocyte hypertrophy. Recent evidence revealed that cardiomyocyte–cardiac fibroblast communications are complex and multifactorial. Many growth factors and molecules contribute to cardiac hypertrophy via different roles that include induction of hypertrophy and the feedback hypertrophic response, fine-tuning of adaptive hypertrophy, limitation of left ventricular dilation, and modification of interstitial changes. This review focuses on recent work and topics and provides a mechanistic insight into cardiomyocyte–cardiac fibroblast communication in cardiac hypertrophy. This article is part of a Special Issue entitled "Myocyte-Fibroblast Signalling in Myocardium ".
Elsevier